NJ Bio is glad to announce that Dr. Srinath (Sri) Thirumalairajan has joined the company as Executive Director of Bioconjugation Chemistry and cGMP Manufacturing. Sri is an experienced Synthetic Organic/Medicinal Chemist with more than a dozen years of industrial experience which include the preparation of bioconjugates, analytical method development/qualification, and the establishment and implementation of safe handling procedures for highly potent APIs (HPAPIs). Prior to joining NJ Bio, Sri held positions as Production Executive at Cipla Ltd. (India), as Research Scientist at Toronto Research Chemicals; as Principal Scientist at The Chemistry Research Solution LLC (TCRS); and most recently as Senior Director of GMP Manufacturing at Abzena, where he was responsible for the process development and cGMP manufacture of ADC constructs and HPAPIs.

In his new role at NJ Bio, Sri will lead the company’s bioconjugation, process development, and manufacturing teams.